CPT code 80323 covers laboratory testing to identify and quantify alkaloid drugs in a patient specimen when no more specific CPT code applies. This specialized toxicology test matters nationally because it supports clinical decision-making in cases of suspected poisoning, overdose, therapeutic monitoring of alkaloid-based therapies, and forensic investigations. The code is relevant to hospitals, outpatient laboratories, and reference labs that perform advanced analytical testing.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service, and the types of services it represents. The publication also summarizes common billing modifiers and payer considerations, national reimbursement context, and how this code fits into laboratory service lines and toxicology workflows. Policy updates, payer coverage patterns, and benchmarking information are discussed where available. Data not available in the input is noted when applicable.